These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production. Knudsen JG; Hamilton A; Ramracheya R; Tarasov AI; Brereton M; Haythorne E; Chibalina MV; Spégel P; Mulder H; Zhang Q; Ashcroft FM; Adam J; Rorsman P Cell Metab; 2019 Feb; 29(2):430-442.e4. PubMed ID: 30415925 [TBL] [Abstract][Full Text] [Related]
24. Possible contribution of taurine to distorted glucagon secretion in intra-islet insulin deficiency: a metabolome analysis using a novel α-cell model of insulin-deficient diabetes. Bessho M; Murase-Mishiba Y; Imagawa A; Terasaki J; Hanafusa T PLoS One; 2014; 9(11):e113254. PubMed ID: 25393115 [TBL] [Abstract][Full Text] [Related]
25. Differentially Expressed MicroRNA-483 Confers Distinct Functions in Pancreatic β- and α-Cells. Mohan R; Mao Y; Zhang S; Zhang YW; Xu CR; Gradwohl G; Tang X J Biol Chem; 2015 Aug; 290(32):19955-66. PubMed ID: 26109062 [TBL] [Abstract][Full Text] [Related]
26. CTCF mediates effect of insulin on glucagon expression. Tsui S; Gao J; Wang C; Lu L Exp Cell Res; 2012 May; 318(8):887-95. PubMed ID: 22426149 [TBL] [Abstract][Full Text] [Related]
27. Uncoupling protein 2 regulates reactive oxygen species formation in islets and influences susceptibility to diabetogenic action of streptozotocin. Lee SC; Robson-Doucette CA; Wheeler MB J Endocrinol; 2009 Oct; 203(1):33-43. PubMed ID: 19635759 [TBL] [Abstract][Full Text] [Related]
30. Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice. da Silva Xavier G; Mondragon A; Mourougavelou V; Cruciani-Guglielmacci C; Denom J; Herrera PL; Magnan C; Rutter GA Diabetologia; 2017 Jun; 60(6):1043-1050. PubMed ID: 28343277 [TBL] [Abstract][Full Text] [Related]
31. Growth factor signalling in the regulation of α-cell fate. Kawamori D; Akiyama M; Hu J; Hambro B; Kulkarni RN Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():21-30. PubMed ID: 21824253 [TBL] [Abstract][Full Text] [Related]
32. Pathways of Glucagon Secretion and Trafficking in the Pancreatic Alpha Cell: Novel Pathways, Proteins, and Targets for Hyperglucagonemia. Asadi F; Dhanvantari S Front Endocrinol (Lausanne); 2021; 12():726368. PubMed ID: 34659118 [TBL] [Abstract][Full Text] [Related]
33. The effect of PPARγ agonist on SGLT2 and glucagon expressions in alpha cells under hyperglycemia. Kim M; Lee EJ; Shin HM; Jung HS; Kim TK; Kim TN; Kwon MJ; Lee SH; Rhee BD; Park JH J Endocrinol Invest; 2017 Oct; 40(10):1069-1076. PubMed ID: 28391584 [TBL] [Abstract][Full Text] [Related]
34. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells? Whalley NM; Pritchard LE; Smith DM; White A J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304 [TBL] [Abstract][Full Text] [Related]
36. Regeneration of pancreatic non-β endocrine cells in adult mice following a single diabetes-inducing dose of streptozotocin. Zhang Y; Zhang Y; Bone RN; Cui W; Peng JB; Siegal GP; Wang H; Wu H PLoS One; 2012; 7(5):e36675. PubMed ID: 22586489 [TBL] [Abstract][Full Text] [Related]
38. MafB Is Critical for Glucagon Production and Secretion in Mouse Pancreatic α Cells Katoh MC; Jung Y; Ugboma CM; Shimbo M; Kuno A; Basha WA; Kudo T; Oishi H; Takahashi S Mol Cell Biol; 2018 Apr; 38(8):. PubMed ID: 29378833 [TBL] [Abstract][Full Text] [Related]
39. Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass. Meier JJ; Ueberberg S; Korbas S; Schneider S Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E717-23. PubMed ID: 21285404 [TBL] [Abstract][Full Text] [Related]